FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023273957> ?p ?o ?g. }

• W2023273957 endingPage "2152" @default.
• W2023273957 startingPage "2144" @default.
• W2023273957 abstract "Lymphatic spread is an important clinical determinant in the prognosis of many human cancers. The lymphangiogenic factor vascular endothelial growth factor-D (VEGF-D) is implicated in the promotion of lymphatic metastasis through the development of lymphatic vessels in some human cancers. In this study, we developed an anti-VEGF-D monoclonal antibody, cVE199, and investigated its in vitro properties, in vivo effects against tumors and possible target indications to evaluate its potential as a therapeutic antibody. The cVE199 molecule was revealed to have a specific binding reactivity against human VEGF-D, as well as a specific inhibitory activity against the binding of human VEGF-D to VEGFR-3. In addition, cVE199 was found to inhibit the biological activity of VEGF-D against lymphatic cells in vitro. Because we determined that a neuroblastoma cell line, SK-N-DZ, abundantly expressed VEGF-D, an in vivo efficacy study was performed using a xenograft model of SK-N-DZ. We found that cVE199 significantly decreased lymphatic metastasis of SK-N-DZ as well as lymphangiogenesis in primary lesions. Finally, we investigated VEGF-D expression in human neuroblastoma, finding that the molecule was expressed in 11 of 29 human neuroblastoma specimens (37.9%). In conclusion, we found that a novel anti-VEGF-D monoclonal antibody, cVE199, with specific reactivity against human VEGF-D, prevents lymphatic metastasis of neuroblastoma through the inhibition of lymphangiogenesis in an animal model. In addition, our results show that VEGF-D is expressed in some cases of human neuroblastomas, which suggests that cVE199 is a potential anti-metastasis therapeutic antibody in neuroblastoma treatment." @default.
• W2023273957 created "2016-06-24" @default.
• W2023273957 creator A5013922845 @default.
• W2023273957 creator A5037187028 @default.
• W2023273957 creator A5039559663 @default.
• W2023273957 creator A5048547119 @default.
• W2023273957 creator A5057149593 @default.
• W2023273957 creator A5072022442 @default.
• W2023273957 date "2012-10-30" @default.
• W2023273957 modified "2023-10-04" @default.
• W2023273957 title "Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor-D" @default.
• W2023273957 cites W1518093405 @default.
• W2023273957 cites W1965014839 @default.
• W2023273957 cites W1969529130 @default.
• W2023273957 cites W1974097718 @default.
• W2023273957 cites W1991328748 @default.
• W2023273957 cites W1994500254 @default.
• W2023273957 cites W1995034367 @default.
• W2023273957 cites W1996706763 @default.
• W2023273957 cites W2002106645 @default.
• W2023273957 cites W2003450086 @default.
• W2023273957 cites W2014908898 @default.
• W2023273957 cites W2018457227 @default.
• W2023273957 cites W2025933554 @default.
• W2023273957 cites W2057102041 @default.
• W2023273957 cites W2057652674 @default.
• W2023273957 cites W2066181739 @default.
• W2023273957 cites W2067606868 @default.
• W2023273957 cites W2070291618 @default.
• W2023273957 cites W2084525401 @default.
• W2023273957 cites W2095525796 @default.
• W2023273957 cites W2118282739 @default.
• W2023273957 cites W2120614448 @default.
• W2023273957 cites W2121431469 @default.
• W2023273957 cites W2130925781 @default.
• W2023273957 cites W2130926603 @default.
• W2023273957 cites W2149304811 @default.
• W2023273957 cites W2150669332 @default.
• W2023273957 cites W2159241628 @default.
• W2023273957 cites W2804842145 @default.
• W2023273957 cites W4211031423 @default.
• W2023273957 doi "https://doi.org/10.1111/cas.12010" @default.
• W2023273957 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7659268" @default.
• W2023273957 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22937829" @default.
• W2023273957 hasPublicationYear "2012" @default.
• W2023273957 type Work @default.
• W2023273957 sameAs 2023273957 @default.
• W2023273957 citedByCount "18" @default.
• W2023273957 countsByYear W20232739572013 @default.
• W2023273957 countsByYear W20232739572014 @default.
• W2023273957 countsByYear W20232739572015 @default.
• W2023273957 countsByYear W20232739572016 @default.
• W2023273957 countsByYear W20232739572018 @default.
• W2023273957 countsByYear W20232739572019 @default.
• W2023273957 countsByYear W20232739572020 @default.
• W2023273957 countsByYear W20232739572021 @default.
• W2023273957 countsByYear W20232739572022 @default.
• W2023273957 crossrefType "journal-article" @default.
• W2023273957 hasAuthorship W2023273957A5013922845 @default.
• W2023273957 hasAuthorship W2023273957A5037187028 @default.
• W2023273957 hasAuthorship W2023273957A5039559663 @default.
• W2023273957 hasAuthorship W2023273957A5048547119 @default.
• W2023273957 hasAuthorship W2023273957A5057149593 @default.
• W2023273957 hasAuthorship W2023273957A5072022442 @default.
• W2023273957 hasBestOaLocation W20232739572 @default.
• W2023273957 hasConcept C103041312 @default.
• W2023273957 hasConcept C121608353 @default.
• W2023273957 hasConcept C126322002 @default.
• W2023273957 hasConcept C142724271 @default.
• W2023273957 hasConcept C146285616 @default.
• W2023273957 hasConcept C150903083 @default.
• W2023273957 hasConcept C159654299 @default.
• W2023273957 hasConcept C167734588 @default.
• W2023273957 hasConcept C181152851 @default.
• W2023273957 hasConcept C202751555 @default.
• W2023273957 hasConcept C203014093 @default.
• W2023273957 hasConcept C207001950 @default.
• W2023273957 hasConcept C2776636583 @default.
• W2023273957 hasConcept C2776715637 @default.
• W2023273957 hasConcept C2777025900 @default.
• W2023273957 hasConcept C2779013556 @default.
• W2023273957 hasConcept C2910366181 @default.
• W2023273957 hasConcept C502942594 @default.
• W2023273957 hasConcept C542903549 @default.
• W2023273957 hasConcept C54355233 @default.
• W2023273957 hasConcept C55493867 @default.
• W2023273957 hasConcept C71924100 @default.
• W2023273957 hasConcept C81885089 @default.
• W2023273957 hasConcept C86803240 @default.
• W2023273957 hasConceptScore W2023273957C103041312 @default.
• W2023273957 hasConceptScore W2023273957C121608353 @default.
• W2023273957 hasConceptScore W2023273957C126322002 @default.
• W2023273957 hasConceptScore W2023273957C142724271 @default.
• W2023273957 hasConceptScore W2023273957C146285616 @default.
• W2023273957 hasConceptScore W2023273957C150903083 @default.
• W2023273957 hasConceptScore W2023273957C159654299 @default.
• W2023273957 hasConceptScore W2023273957C167734588 @default.
• W2023273957 hasConceptScore W2023273957C181152851 @default.

• next